ALMAC CLINICAL SERVICES

NBD Company Number:35N100216195

Address:25 FRETZ ROAD SOUDERTON PA 18964 US

The latest trade data of this company is 2024-09-30

UNITED STATES Importer/Exporter

Data Source:Customs Data

Records:6397 Buyers:267 Suppliers:25

Related Product HS Code: 30049000 30049039 30049099 39231000 39233010 39269097 90183110

Related Trading Partners: SOMERSET THERAPEUTICS LTD. , NOLATO CERBO AB , MYLAN LABORATORIES LIMITED, MORE

ALMAC CLINICAL SERVICES was included in the global trader database of NBD Trade Data on 2020-12-02. It is the first time for ALMAC CLINICAL SERVICES to appear in the customs data of the UNITED STATES,and at present, NBD Customs Data system has included 6397 customs import and export records related to it, and among the trade partners of ALMAC CLINICAL SERVICES, 267 procurers and 25 suppliers have been included in NBD Trade Data.

ALMAC CLINICAL SERVICES 2020 Present Trade Trend Statistics
Year Import/Export Partner Count Category Count Region Count Entries Total Total Value
2023 Export 101 46 11 1861 0
2023 Import 8 3 4 21 0
2022 Export 101 54 12 1931 0
2022 Import 9 6 3 41 0
2021 Export 114 46 9 669 0
2021 Import 3 2 3 9 0
2020 Export 37 30 7 579 0
2020 Import 3 2 2 12 0

Become a member: Inquire the Trade data, download the trade data!

Using NBD Trade Data can help the users comprehensively analyze the main trade regions of ALMAC CLINICAL SERVICES , check the customs import and export records of this company in NBD Trade Data System till now, master the upstream and downstream procurers and suppliers of this company, find its new commodities procured or supplied, search the contact information of ALMAC CLINICAL SERVICES and the procurement decision maker's E-mail address. NBD Trade Data System is updated once every three days. At present, the latest trade data of this company have been updated until 2024-09-30.

Recent customs import and export records of ALMAC CLINICAL SERVICES are as follows:

Date Imp & Exp HS CODE Product Description Country Imp or Exp Company Details
2024-09-18 Import 30049099 OSIMERTINIB TABLETS, BOX (DOSEPAK) CONTAINING 10 X 80MG TABLETS. MANUFACTURER ASTRAZENECA AB. USED GOODS.#&SE VIETNAM B***G More
2024-09-18 Import 30049099 TEPOTINIB, TABLETS. BOX (DOSEPAK) 14 X 250MG TABLETS. MANUFACTURER MERCK KGAA. USED GOODS.#&DE VIETNAM B***G More
2024-09-18 Import 30049099 OSIMERTINIB TABLETS, BOX (DOSEPAK) CONTAINING 10 X 80MG TABLETS. MANUFACTURER ASTRAZENECA AB. USED GOODS.#&SE VIETNAM B***G More
2024-09-18 Import 30049099 OSIMERTINIB TABLETS, BOX (DOSEPAK) CONTAINING 10 X 80MG TABLETS. MANUFACTURER ASTRAZENECA AB. USED GOODS.#&SE VIETNAM B***G More
2024-09-18 Import 30049099 TEPOTINIB, TABLETS. BOX (DOSEPAK) 14 X 250MG TABLETS. MANUFACTURER MERCK KGAA. USED GOODS.#&DE VIETNAM B***G More
2024-10-31 Export 3004391900 WEGOVY (SEMAGLUTIDA), S/M, S/M INYECCION SUBCUTANEA 01 VIAL/KIT 0.5MG/0.5ML (81019668) / LOT: Y008129 // EXPIRA: 30-ABR-2025 // PROTOCOLO: MK-6024-013-01 LAPICERO INYECTOR PRECARGADO DE DOSIS UNICA CON SOLUCION ESTERIL PARA PERU M***. More
2024-10-31 Export 3004391900 WEGOVY (SEMAGLUTIDA), S/M, S/M INYECCION SUBCUTANEA 01 VIAL/KIT 0.25MG/0.5ML (81020391) / LOT: Y009095 // EXPIRA: 28-FEB-2025 // PROTOCOLO: MK-6024-013-01 LAPICERO INYECTOR PRECARGADO DE DOSIS UNICA CON SOLUCION ESTERIL PARA PERU M***. More
2024-10-31 Export 3004391900 WEGOVY (SEMAGLUTIDA), S/M, S/M INYECCION SUBCUTANEA 01 VIAL/KIT 2.4MG/0.75ML (81019888) / LOT: Y002066 // EXPIRA: 31-AGO-2025 // PROTOCOLO: MK-6024-013-01 LAPICERO INYECTOR PRECARGADO DE DOSIS UNICA CON SOLUCION ESTERIL PARA PERU M***. More
2024-10-31 Export 3004902400 TALAZOPARIB 0.1MG, PFIZER, S/M INGREDIENTE FARMACEUTICO ACTIVO.TOSILATO DE TALAZOPARIB // PARA EL ENSAYO CLINICO TITULADO CARTA N° 3641-2024-DIGEMID-DPF/MINSA FRASCO CON 30CAPSULAS/VIA ORAL,LOTE.24-BU-01086, MANUF.02.08.2022,EXPIRA.31.08.2025 Talazoparib 0 PERU P***A More
2024-10-31 Export 3004902400 TALAZOPARIB 0.25MG, PFIZER, S/M LOTE.24-BU-01090, MANUF.18.09.2023,EXPIRA.28.02.2027 // CARTA N° 3641-2024-DIGEMID-DPF/MIN PARA EL ENSAYO CLINICO TITULADO,ESTUDIO DE FASE 3. // INGREDIENTE FARMACEUTICO ACTIVO.TOSI FRASCO CON 30CAPSULAS/VIA ORAL,LOTE.24-BU- PERU P***A More